305 related articles for article (PubMed ID: 10802380)
41. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.
Schepkin VD; Lee KC; Kuszpit K; Muthuswami M; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
NMR Biomed; 2006 Dec; 19(8):1035-42. PubMed ID: 16894643
[TBL] [Abstract][Full Text] [Related]
42. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Hoshino T; Barker M; Deen DF
Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
44. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
[TBL] [Abstract][Full Text] [Related]
45. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
[TBL] [Abstract][Full Text] [Related]
46. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging.
Rehemtulla A; Stegman LD; Cardozo SJ; Gupta S; Hall DE; Contag CH; Ross BD
Neoplasia; 2000; 2(6):491-5. PubMed ID: 11228541
[TBL] [Abstract][Full Text] [Related]
47. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
[TBL] [Abstract][Full Text] [Related]
48. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
49. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Deen DF; Oredsson SM; Marton LJ
Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
[TBL] [Abstract][Full Text] [Related]
50. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
[TBL] [Abstract][Full Text] [Related]
51. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
52. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model.
Kimler BF; Liu C; Evans RG; Morantz RA
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):445-50. PubMed ID: 8514542
[TBL] [Abstract][Full Text] [Related]
53. Synergistic effect of perfluorochemicals on BCNU chemotherapy. Experimental study in a 9L rat brain-tumor model.
Kuwamura K; Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1982 Oct; 57(4):467-71. PubMed ID: 7108595
[TBL] [Abstract][Full Text] [Related]
54. Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model.
Lee A; DeJong G; Guo J; Bu X; Jia WW
Cancer Gene Ther; 2000 Aug; 7(8):1113-9. PubMed ID: 10975671
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
56. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract][Full Text] [Related]
57. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
[TBL] [Abstract][Full Text] [Related]
58. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
[TBL] [Abstract][Full Text] [Related]
59. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
Giese A; Bock HC; Kantelhardt SR; Rohde V
Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
[TBL] [Abstract][Full Text] [Related]
60. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]